Financial Data and Key Metrics Changes - For the fiscal year ending June 30, 2025, total revenue increased by 11% from $20.5 million to $22.6 million [5] - Recurring revenue rose by 10% to $22.3 million, with setup fees increasing from $95,000 in fiscal 2024 to over $300,000 in fiscal 2025 [5] - Total operating expenses increased by 6%, primarily due to investments in RTN and other development costs [5] - Fiscal year income from operations increased by 24% to $6.2 million, while GAAP net income rose by 17% to $7 million [7] - Earnings per share for fiscal year 2025 was $0.36 basic and $0.35 diluted, reflecting a year-over-year EPS growth of 21% [8] - Cash from operations increased by 21% from $7 million to $8.4 million, and total cash rose by 14% from $25.2 million to $28.6 million [8] Business Line Data and Key Metrics Changes - Annual recurring revenue continues to represent between 98% and 99% of total revenue, indicating strong stability in recurring income [8] - The increase in deferred revenue was 30%, from $2.4 million to $3.2 million, indicating future revenue growth [12] Market Data and Key Metrics Changes - The company is experiencing growth across all lines of business, including compliance and supply chain, not just traceability [11] - The traceability initiative has expanded the target market significantly, allowing the company to engage with smaller accounts effectively [19] Company Strategy and Development Direction - The company's strategy focuses on growing annual recurring revenue between 10% to 20% while increasing profitability at a faster rate [4] - The management emphasizes a customer-centric approach, ensuring exceptional service to drive further sales [15] - The company aims to enhance its contribution margin from approximately 50% towards 80% through investments in automation and efficiency [15] Management's Comments on Operating Environment and Future Outlook - Management remains confident in the company's growth trajectory, expecting to double the size of the company over the next several years [10] - The company is adapting to market changes and regulatory requirements, particularly in traceability, which is seen as a significant growth opportunity [26] Other Important Information - The company has zero bank debt and has been actively returning capital to shareholders through share buybacks and dividends [16][17] - The capital allocation strategy includes redeeming preferred shares and increasing common stock dividends [17] Q&A Session Summary Question: Did you change your pricing or billing strategy? - The company has not fundamentally changed its pricing or billing strategy but has found that automation allows them to effectively serve smaller accounts as well as larger ones [30][31] Question: How have tariffs impacted your business? - Currently, tariffs have not significantly impacted the business, but there is potential for future effects on the food supply chain [32][33] Question: What are your thoughts on strategic M&A? - The company is open to M&A opportunities that are accretive and would enhance their service offerings or market reach [35][36] Question: Would you consider paying a one-time dividend? - Management prefers to focus on increasing regular dividends rather than issuing a one-time dividend, as it provides more consistent value to shareholders [38][39] Question: Do you have any crypto treasury plans? - The company has no plans to invest in cryptocurrency, viewing it as too risky and preferring to focus on their established capital allocation strategy [43][44]

Financial Data and Key Metrics Changes - For the full fiscal year ending June 30, 2025, total revenue increased 11% from $20.5 million to $22.6 million [5] - Recurring revenue increased 10% to $22.3 million [5] - GAAP net income was $7 million, up 17% from $6 million last year [7] - Earnings per share for fiscal year 2025 was $0.36 basic and $0.35 diluted, resulting in a year-over-year EPS growth of 21% [8] - Cash from operations increased 21% from $7 million to $8.4 million [8] - Total cash increased 14% from $25.2 million to $28.6 million, with zero bank debt [8][10] Business Line Data and Key Metrics Changes - Setup fees increased from $95,000 in fiscal 2024 to over $300,000 in fiscal 2025 due to an increased number of suppliers onboarded [5] - Annual recurring revenue continues to represent between 98% and 99% of total revenue [8] - Deferred revenue increased 30% from $2.4 million to $3.2 million, indicating future revenue growth [5][12] Market Data and Key Metrics Changes - The company is experiencing growth in all lines of business, including compliance and supply chain, not just traceability [11] - The traceability network is becoming increasingly significant, with a growing number of referrals from suppliers and manufacturers [22][25] Company Strategy and Development Direction - The company aims to grow annual recurring revenue between 10% to 20% and grow profitability even faster [4] - A focus on automation and efficiency is key to expanding the addressable market, particularly targeting smaller accounts [18][19] - The company is positioning itself as a go-to source for traceability solutions, leveraging a common technology platform for cross-selling opportunities [26][27] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued growth and profitability, aiming to double the size of the company over the next several years [10] - The FDA's change in timeline for compliance has provided breathing room for effective rollout of services [26] - The company plans to maintain a strong balance sheet with no debt while returning capital to shareholders through dividends and stock buybacks [15][17] Other Important Information - The company has paid out over $5 million in cash dividends to shareholders and has increased the common stock dividend three times by 10% each since December 2023 [17] - The capital allocation strategy includes redeeming preferred shares and buying back common stock, with $8 million remaining for future buybacks [16] Q&A Session Summary Question: Did you change your pricing or billing strategy? - The company has not changed its pricing strategy but can now effectively serve smaller accounts due to automation, expanding its market reach [30][31] Question: How have tariffs impacted your business? - Currently, tariffs have not significantly impacted the business, but there is potential for future effects on the food supply chain [32][33] Question: What are your thoughts on strategic M&A? - The company is open to M&A opportunities that are accretive and would provide new customers or enter adjacent industries [35][36] Question: Would you consider paying a one-time dividend? - Management prefers to focus on increasing regular dividends rather than one-time payouts, emphasizing a consistent return strategy [38][39] Question: Do you have any crypto treasury plans? - The company has no plans to invest in crypto, viewing it as too risky and preferring to focus on its capital allocation strategy [43][44]